Pancreatic Cancer Research

ResearcherUniversity of RochesterNo recent work listed

Alan W. Katz

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2466-2714; OpenAlex author ID A5035857272. Sources: ClinicalTrials.gov.

Their work

Papers
2
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2013: 1 paper · 2014: 1 trial · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. Modulation of the Human Pancreatic Ductal Adenocarcinoma Immune Microenvironment by Stereotactic Body Radiotherapy. Co-author DOI 10.1158/1078-0432.ccr-21-2495↗
  2. Unresectable locally advanced pancreatic cancer: treatment with neoadjuvant leucovorin, fluorouracil, irinotecan, and oxaliplatin and assessment of surgical re… Co-author DOI 10.1200/jco.2012.44.0339↗

Trials 1

  1. Pilot Study of Short-Course Preoperative Stereotactic Body Radiation Therapy for Resectable Pancreatic Cancer Principal investigator NCT02347618↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. David C. Linehan · 1 shared paper, 2022 · strength 0.13
  2. Bradley N. Mills · 1 shared paper, 2022 · strength 0.13
  3. Joseph D. Murphy · 1 shared paper, 2022 · strength 0.13
  4. Scott A. Gerber · 1 shared paper, 2022 · strength 0.13
  5. Jian Ye · 1 shared paper, 2022 · strength 0.13
  6. Haoming Qiu · 1 shared paper, 2022 · strength 0.13
  7. Esther Liu Mondo · 1 shared paper, 2013 · strength 0.05
  8. Aram F. Hezel · 1 shared paper, 2013 · strength 0.05
  9. Marcus Smith Noel · 1 shared paper, 2013 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.